Feng RenChief Scientific Officer, Executive Director & Co-CEO · Insilico MedicineResearcher↗
Founder · Executive · Researcher
Alex Zhavoronkov
Insilico MedicineFounder, Chair and CEO
Zhavoronkov helped popularize the use of deep learning and generative models in aging research and drug discovery. At Insilico, he pushed AI-designed targets and molecules toward clinical testing, including fibrosis programs, and promoted Pharma.AI as an end-to-end discovery platform. He has also written on longevity economics and authored The Ageless Generation.
Career & education
Current role
Insilico Medicine2014-presentFounder, Chair and CEO
Insilico Medicine2014-presentWork and education history is primarily focused on AI-relevant roles and may not be comprehensive.
Based on public sources. If accuracy is important, verify details using the links or references.
For corrections, updates, or requests to remove information, contact us.
Reviewed August 18, 2026 · Checked for accuracy and new information.
Queen's University
Johns Hopkins University
Lomonosov Moscow State University